NCT03039049View on ClinicalTrials.gov

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Infertility
Interventions
DRUG

Triptorelin 0.1 mg

a single dose of Triptorelin 0.1 mg subcutaneously administered 6 days after oocyte retrieval.

Trial Locations (2)

25000

Ibnrochd Clinic, Constantine

Ibnrochd IVF center, Constantine

All Listed Sponsors
lead

Centre Hospitalier Universitaire Ibn Rochd

OTHER

NCT03039049 - GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT | Biotech Hunter | Biotech Hunter